I don’t think these sorts of companies need constant news flow....

I don’t think these sorts of companies need constant news flow. Biotech is just a boring game of patience, pretty difficult to make trials or their results any faster.

For my money, the best bit of newsflow was the deal with Sonic. I’m reasonably confident that SHL has much better DD than I am capable of, consequently I don’t give MAP too much thought however I do seem to see a fair bit from them on LinkedIn. Maybe that’s just part of an algorithm that LinkedIn has added to my account and thinks I’m pretty keen on anything that mentions MAP??